LivaNova PLC (LIVN)

Cardiopulmonary and neuromodulation devices. Read November 8, 2026 from the annual report for the period ending December 31, 2025, filed February 25, 2026. Ranked 39 of the 145 Healthcare companies read so far, by the share within reach now.

A medical device company with about 3,300 employees in 34 countries, read whole at electromedical instruments by description.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 36% now, 49% at the end of 2027, 53% at the end of 2028, 54% at the end of 2030. By the patterns, the work is about 54% desk work, 18% people work and 28% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 46% of the working time stays with people (conversation, in-person and hands-on work), 47% becomes checking a model's work and 5% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

3,300 employees as of December 31, 2025 (stated). Not stated; employees in 34 countries, and 53% of revenue in the United States.

The filing: “As of December 31, 2025, LivaNova had approximately 3,300 employees worldwide, representing more than 80 nationalities and located in 34 countries.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 3,300 employees worldwide, more than 80 nationalities, 34 countries; over 94% completed the 2026 engagement survey.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Navigational, Measuring, Electromedical, and Control Instruments Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.

• Medtronic plc (MDT, 95,000 employees)33% now, 46% by 2028
• Emerson Electric Co. (EMR, 71,000 employees)36% now, 51% by 2028
• Danaher Corporation (DHR, 60,000 employees)34% now, 48% by 2028
• GE HealthCare Technologies Inc. (GEHC, 54,000 employees)37% now, 53% by 2028
• L3Harris Technologies, Inc. (LHX, 45,000 employees)35% now, 51% by 2028
• Rockwell Automation, Inc. (ROK, 26,000 employees)42% now, 61% by 2028
• Garmin Ltd. (GRMN, 23,000 employees)36% now, 53% by 2028
• AMETEK, Inc. (AME, 22,500 employees)32% now, 45% by 2028

What the filing says about AI

17 sentences in the filing name AI. Seventeen sentences, mostly definitions and risk: research and development investment includes technology, AI and software, with AI among the risks the forward-looking statements name.

• “Abbreviation Definition 2015 Plan LivaNova PLC 2015 Incentive Award Plan 2021 First Lien Credit Agreement First Lien Credit Agreement between LivaNova PLC and its wholly-owned subsidiary, LivaNova USA, Inc., and Goldman Sachs Bank USA, as First Lien Administrative Agent and First Lien Collateral Agent, entered into on August 13, 2021 2022 The year ended December 31, 2022 2023 The year ended Dec...”
• “There are a number of risks, uncertainties, and other important factors, many of which are beyond the Company's control, that could cause the Company's actual results to differ materially from the forward-looking statements contained in this Report, and include, but are not limited to, the following risks and uncertainties: volatility in the global market and worldwide economic conditions; adve...”
• “R&D The Company's R&D investment consists of product design and development expenses, including technology, AI, software, clinical study programs, and regulatory activities.”
• “LivaNova's markets are subject to rapid technological advances, and as such, product improvement, incorporation of AI, software advancements, and innovation are necessary to maintain market leadership.”
• “Additionally, AI and machine learning may be used for certain cybersecurity incidents, improving or expanding the existing capabilities of threat actors in manners the Company cannot predict at this time, resulting in greater risk of cybersecurity incidents.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20230median 1
• Fiscal 20242median 4
• Fiscal 202517median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• The U.S. share is not stated.

Source: the company's annual report on EDGAR, accession 0001639691-26-000010, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.